Pharma's Problems

In an analysis column in the British Medical Journal, York University's Joel Lexchin and Donald Light from the University of Medicine and Dentistry of New Jersey say that the "widely touted 'innovation crisis' in pharmaceuticals is a myth," and that the real problem in pharma is that current incentives reward companies for making drugs that are only marginally better than existing products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Put It in the Jar

It's No Potato Clock

Primetime Bioethics

Mostly Down

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

The New York Times editorial board weighs in on scientific research misconduct.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.